These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28215180)

  • 1. Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects.
    Suvarna H I S; Moodithaya S; Sharma R
    Curr Aging Sci; 2017; 10(3):201-210. PubMed ID: 28215180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of glycated haemoglobin (HbA1
    Mustafa IO; Tanko Y; Yusuf R; Musa SA
    Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes.
    Nuamchit T; Siriwittayawan D; Thitiwuthikiat P
    Vasc Health Risk Manag; 2020; 16():343-352. PubMed ID: 32943869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial.
    Tuttolomondo A; Cirrincione A; Casuccio A; Del Cuore A; Daidone M; Di Chiara T; Di Raimondo D; Corte VD; Maida C; Simonetta I; Scaglione S; Pinto A
    Cardiovasc Diabetol; 2021 Jan; 20(1):1. PubMed ID: 33397395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes.
    Berra CC; Resi V; Mirani M; Folini L; Rossi A; Solerte SB; Fiorina P
    Pharmacol Res; 2020 Sep; 159():104996. PubMed ID: 32574827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Nowrouzi-Sohrabi P; Rezaei S; Jalali M; Ashourpour M; Ahmadipour A; Keshavarz P; Akbari H
    Eur J Pharmacol; 2021 Feb; 893():173823. PubMed ID: 33352183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study.
    Zaccardi F; Rocca B; Rizzi A; Ciminello A; Teofili L; Ghirlanda G; De Stefano V; Pitocco D
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):902-909. PubMed ID: 28838851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
    Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
    Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus.
    Cho JH; Kim HJ; Lee JH; Park IR; Moon JS; Yoon JS; Lee IK; Won KC; Lee HW
    Korean J Intern Med; 2016 Jul; 31(4):703-11. PubMed ID: 27271351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study.
    Gomez-Sanchez L; Garcia-Ortiz L; Patino-Alonso MC; Recio-Rodriguez JI; Feuerbach N; Marti R; Agudo-Conde C; Rodriguez-Sanchez E; Maderuelo-Fernandez JA; Ramos R; Gomez-Marcos MA;
    PLoS One; 2017; 12(4):e0175982. PubMed ID: 28414819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.
    Chen S; Shen Y; Liu YH; Dai Y; Wu ZM; Wang XQ; Yang CD; Li LY; Liu JM; Zhang LP; Shen WF; Ji R; Lu L; Ding FH
    Cardiovasc Diabetol; 2021 Mar; 20(1):64. PubMed ID: 33714276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of glycemic control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus.
    Brassard P; Ferland A; Bogaty P; Desmeules M; Jobin J; Poirier P
    Metabolism; 2006 Nov; 55(11):1532-7. PubMed ID: 17046557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA.
    Fofonka A; Ribeiro JP; Casali KR; Schaan BD
    Trials; 2014 Nov; 15():424. PubMed ID: 25366037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
    Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
    Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.